ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
70 hedge funds and large institutions have $896M invested in ESSA Pharma in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 6 closing their positions.
500% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 6
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
227% more capital invested
Capital invested by funds: $274M → $896M (+$621M)
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
75% more funds holding
Funds holding: 40 → 70 (+30)
22.48% more ownership
Funds ownership: 68.8% → 91.28% (+22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$42.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$31.4M |
| 3 |
Janus Henderson Group
London,
|
+$23.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$18.5M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$11.6M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$8.57M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$7.1M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$6.56M |
EPIX Hedge Fund Activity: Q1 2021 in Review
70 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q1 2021, worth a combined $896M — up 227% from $274M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new EPIX positions and 6 closed out — a net gain of 30 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was Bellevue Group, opening a new position worth an estimated $42.4M. The largest seller was BVF Inc, cutting an estimated $18.5M.
- 70 institutional investors held ESSA Pharma (EPIX) as of Q1 2021, up from 40 in Q4 2020.
- Funds reported $896M of ESSA Pharma stock for Q1 2021, up 227% quarter-over-quarter.
- 36 funds opened new ESSA Pharma positions in Q1 2021 and 6 closed out, a net change of +30 holders.
- The largest ESSA Pharma buyer in Q1 2021 was Bellevue Group, an estimated $42.4M added.
- The largest ESSA Pharma seller in Q1 2021 was BVF Inc, an estimated $18.5M sold.
Based on aggregated 13F filings for Q1 2021.